All News
Why Childhood SLE is More Severe than Adult SLE
d
             
          
          About 10 to 20% of all lupus patients are children, and the criteria to make the diagnosis of lupus are the same in pediatrics and adults. Why is pediatric lupus often more severe than adult-onset disease?
Read Article
          Why follow antiDNA and complements in
#lupus #nephritis #LN
#LUPUS2025 panel said 
To detect flare
?to consider after 3 to 5 yrs of remission to taper Rx
?but not for early response to Rx
Just info from the panel with my opinion salted in
@RheumNow https://t.co/bFUfN0PsFF
                       
              
          
          
            
              
 
            
          
        
      Links:
             Janet Pope Janetbirdope ( View Tweet)
            
            
  
          deep thoughts in #lupus
Is ‘better’ the enemy of #remission?
Is a complete renal response <50% at the end of contemporary #triple #therapy
Something to celebrate?
▶️Yes better than old #SoC but a bit sobering
We need RCTs that radically change paradigm
#LUPUS2025  @RheumNow
        
                Janet Pope Janetbirdope ( View Tweet)
          Who with +ANA will become #SLE
Mostly similar cytokine signature 
But ⬆️IFN and 
more innate immune changes 
👇
In those who developed #lupus
? prediction & Prevention model in +#ANA people 🤷♀️
yr in review E Vital’s paper
#LUPUS2025 @RheumNow @ZahiTouma https://t.co/khpqRlH8Nk
                      
          
          
            
              
 
            
          
        
      
             Janet Pope Janetbirdope ( View Tweet)
            
            
          ‘Oranges & green vegetables’
⬆️
#diarrhea in #MMF said Ana Malvar 
bad #LN outcomes if #nonadherent
Good relationship with#HCP helps 
#adherence 
✅education to help deal with side effects 
pts need to know 
Why this Rx 
?how long
S|E Rx
#ClinicalPearl 
#LUPUS2025 
@RheumNow https://t.co/RnFGwJSl1F
                      
          
          
            
              
 
            
          
        
      
             Janet Pope Janetbirdope ( View Tweet)
            
            
          Who does worse with #SLE
#nature vs #nurture 
South American #lupus #registries 
⬆️ activity
⬆️damage
⬇️age
⬇️SES
⬆️SLE #antibodies 
#Gladel registry and others vs Europe 
Environment >genetics 🤔
#LUPUS2025 #45poster @RheumNow 
@gponsestel https://t.co/XjiXHAMuGm
                       
              
          
          
            
              
 
            
          
        
      Links:
             Janet Pope Janetbirdope ( View Tweet)
            
            
          do’s & don’t #Lupus #nephritis 
❎
Don’t sequential monotherapy
▶️ use #MMF + #biologic or #CNI
✅
Do a #biopsy 
➡️ need to know
#dx 
#px
Do target LOW proteinuria 
Do treat comorbidities 
Lipids
HTN
Fluids
BMI
?mood
No #NSAIDs
Do limit #pred
#SGLT2i 
@RheumNow #LUPUS2025 https://t.co/D0vHQXYTvZ
                       
              
          
          
            
              
 
            
          
        
      Links:
             Janet Pope Janetbirdope ( View Tweet)
            
            
          Impt predictors of 
#neuropsychiatric #SLE
#LUPUS2025 @RheumNow 
No major predictors 
But if explanation of other conditions ex 
Past #cvA
#ischemic events 
Doesn’t have to have
➡️Active systemic ##Lupus 
➡️ ?ribosomalP
+Abs described in #CNS lupus 
A real headache! https://t.co/iuWfB454EN
                      
          
          
            
              
 
            
          
        
      
             Janet Pope Janetbirdope ( View Tweet)
            
            
          ‘It’s #Lupus, it’s all in your head!’
➡️ Some patients with #SLE have heard this from others 
At #LUPUS2025 in a packed session on #CNS lupus 
#Dx is tricky 
40% of #neuropsychiatric lupus have NEGATIVE #brain #MRI
👇r/o 
infarct/bleed
Infection 
Rx #steroids 
@RheumNow https://t.co/yU1olg0uZU
                       
              
          
          
            
              
 
            
          
        
      Links:
             Janet Pope Janetbirdope ( View Tweet)
            
            
  
          Steroids prevention of #congenital #heart #block in +Ro 
Mom
#DM #HTN #wt⬆️
Fetus 
?no diff #cardiomyopathy 
?learning &behavioural changes
Debate re screen #CHB
Most CHB are kids w CHB as mom is unknown to be +Ro
Angst w screening
High titre Ro Impt 
@RheumNow  #LUPUS2025
        
                Janet Pope Janetbirdope ( View Tweet)
  
          Do you routinely recommend SLE +Ro/La  pregnant Pts to have routine screening for #congenital #heart #block
#LUPUS2025 @RheumNow
        
                Janet Pope Janetbirdope ( View Tweet)
          ‘To screen or not’?
For
#CHB #congenital #heart #block
Great debate #LUPUS2025
In #pregnant women with #SLE
In + #Ro #SSA &/or #La #SSB mothers 
CHB Rx - #flourinated #steroids 
To
⬇️#fetal #mortality ❎no benefit
⬇️#cardiomyopathy ❎
⬇️#pacemaker ❎
@RheumNow 
??🤷♀️ https://t.co/xauDzfNBsC
                      
          
          
            
              
 
            
          
        
      
             Janet Pope Janetbirdope ( View Tweet)
            
            
          Level up 🆙 
#hydroxychloroquine #levels in #SLE 
When 
to determine adherence - too low
To see if levels are supratherapeutic 
Who 
SLE Pts who have risks for #HCQ toxicity#CKD, liver dx, age, overdosing
Why
Safety
Adherence 
@RheumNow #LUPUS2025 https://t.co/l8FPcqmTki
                      
          
          
            
              
 
            
          
        
      
             Janet Pope Janetbirdope ( View Tweet)
            
            
          #Proteinuria that persists in #LN 
#lupus #nephritis even w mild proteinuria 
👇
Worse outcomes 
Just like all CKD
Take home
Aim for None or minimal in #SLE
<150 protein
#voclosporin >> PBO (SoC)
1/2 Voclosporin had deep response at least once > PBO
#LUPUS2025 @RheumNow https://t.co/CBUzyBatBh
                       
              
          
          
            
              
 
            
          
        
      Links:
             Janet Pope Janetbirdope ( View Tweet)
            
            
          Any ‘toll’ in #toll #like #receptors 7,8 in #SLE
Cutaneous #lupus 
In #systemic or #cutaneous  wk16
Rx 
PBO
V
#enpatoran
No obvious dose response - all 3 dose >PBO
Safe so far improves IFN
No toll to pay! 👍
But need Ph3 data
#LUPUS2025 @EricFMorand @RheumNow https://t.co/2DDztlVsUm
                       
              
          
          
            
              
 
            
          
        
      Links:
             Janet Pope Janetbirdope ( View Tweet)
            
            
          Systematic review and meta-analysis confirms modest efficacy of infliximab for pulmonary sarcoidosis and promising but limited evidence for adalimumab, tofacitinib and efzofitimob in specific sarcoid manifestations. https://t.co/XaqSiAVQTa https://t.co/DTGbIiPT3a
                      
          
          
            
              
 
            
          
        
      
             Dr. John Cush RheumNow ( View Tweet)
            
            
          Systemic sclerosis is a vasular disorder! Microvascular dysfunction, Endotheliopathy, & reduced vascular reserve account for most findings. Good review w/ literature references in Arthritis Research & Therapy.  https://t.co/ULfwBy7ECb https://t.co/QnpImUrA7q
                      
          
          
            
              
 
            
          
        
      
             Dr. John Cush RheumNow ( View Tweet)
            
            
          Is Lupus Just a B Cell Disorder? 
https://t.co/0kwxE6KLeI https://t.co/pORHkg9HY6
                      
          
          
            
              
 
            
          
        
      
             Dr. John Cush RheumNow ( View Tweet)
            
            
          Moving Targets in Lupus and Lupus Trials 
In the 1990s, lupus treatment development became a major focus, but progress was slow. Belimumab was eventually approved by recognizing that trials could only show small differences from placebo, requiring 867 patients globally to https://t.co/xrj8r1iNxr
          
          
            
              
 
            
          
        
      
             Dr. John Cush RheumNow ( View Tweet)
            
            
  
          Assessing neuropsychiatric SLE by 3-T, 3D contrast-enhanced vessel wall imaging. 47 w/ NPSLE vs 42 without (just SLE) showed the NPSLE had 2 fold more 1ntracranial contrast-enhanced vessel wall imaging (CE-VWI) w/ AUC  0.78 for CE-VWLs, & sensitivity 60% , specificity  87%.
        
                Dr. John Cush RheumNow ( View Tweet)
        
    

